Alto: Now Is The Time? (Inverse H&S)

10월 19일

It's been a long time since I posted.
My next move is Alto Neuroscience.
What I am looking at is an inverse head and shoulder. I think a lot of people doubt this company because it's just another pharma company and see it as a risky trial phase play.
But these guys have a trick up their sleeve, they are juicing their trials by looking for bio-markers that make their trial drugs more effective. They call it precision medication, identifying who will be receptive to the treatment before the treatment is given.

These drugs already work in mixed results, for some it works great and for others it offers mild benefit, so if they are able to identify through bio markets who it works better for and they only do trials on those people what do you think the results will be?

Its a bit of a gamble, but I think it could pay off.

I am feeling bullish on ANRO